PATENT CLAIM ANALYSIS

Application Number: 15985617
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["424", "722000"]

Abstract:
A Direct Sodium Removal method, apparatus and solution for treating patients in heart failure, and having a glomerular filtration rate greater than 15 mL/min/1.73 m 2 , or residual kidney function corresponding to normal to CKD Stage 4, is provided in which a no or low sodium DSR infusate is administered to the peritoneal cavity for a predetermined dwell period and then removed, thereby removing sodium from the body. The resulting elimination of fluid from the patient by i) functioning of the kidneys through urination and ii) direct removal of osmotic ultrafiltrate from the peritoneal cavity, restores serum sodium concentrations to healthy levels and thereby reduces fluid overload in the patient.

Claim (Index 21):
The method of  claim 13 , further comprising monitoring an intra-abdominal pressure of the patient with one or more sensors.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 93.0
- Lexical Diversity: 1.44578
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14077005', '13397498', '15965727', '14856447', '13397509']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7342908249401925
- 35 USC 102 Novelty (BERT): 0.5063741746847694
- Combined Prediction Score: 0.7114991599146502
- Mean Citation Score: 245.35329
- Max Citation Score: 265.08475
- Similarity Product: 179.78021056427062

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test